Altered expression of p120catenin predicts poor outcome in invasive breast cancer
- 12 February 2010
- journal article
- Published by Springer Science and Business Media LLC in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 136 (9), 1377-1387
- https://doi.org/10.1007/s00432-010-0789-8
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Proliferation marker securin identifies favourable outcome in invasive ductal breast cancerBritish Journal of Cancer, 2008
- A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic DiseaseJournal of Biological Chemistry, 2008
- Reduction of p120ctn isoforms 1 and 3 is significantly associated with metastatic progression of human lung cancerAPMIS, 2007
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Inducible expression of p120Cas1B isoform corroborates the role for p120-catenin as a positive regulator of E-cadherin function in intestinal cancer cellsBiochemical and Biophysical Research Communications, 2004
- Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesionsOncogene, 2004
- New methods for testing linear separabilityNeurocomputing, 2002
- Expression patterns of β-catenin in in situ and invasive breast cancerEuropean Journal of Surgical Oncology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Molecular Cloning of the Human p120ctnCatenin Gene (CTNND1): Expression of Multiple Alternatively Spliced IsoformsGenomics, 1998